Use of Sodium–Glucose Cotransporter 2 (SGLT-2) Inhibitors Beyond Diabetes: On the Verge of a Paradigm Shift?. (2020). Rhythmos, 15(1), 1-5. https://www.rhythmos.gr/index.php/Rhythmos/article/view/473